Free Trial

ThermoGenesis (THMO) Competitors

ThermoGenesis logo
$0.0006
0.00 (0.00%)
(As of 11/1/2024 ET)

THMO vs. OLITW, PCCTW, PRENW, QSIAW, SMAPW, KEQU, MSON, TT, KEYS, and FTV

Should you be buying ThermoGenesis stock or one of its competitors? The main competitors of ThermoGenesis include OmniLit Acquisition (OLITW), Perception Capital Corp. II (PCCTW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Kewaunee Scientific (KEQU), Misonix (MSON), Trane Technologies (TT), Keysight Technologies (KEYS), and Fortive (FTV).

ThermoGenesis vs.

ThermoGenesis (NASDAQ:THMO) and OmniLit Acquisition (NASDAQ:OLITW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

ThermoGenesis received 26 more outperform votes than OmniLit Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
ThermoGenesisOutperform Votes
26
60.47%
Underperform Votes
17
39.53%
OmniLit AcquisitionN/AN/A

OmniLit Acquisition has lower revenue, but higher earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.140.00
OmniLit AcquisitionN/AN/AN/AN/AN/A

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled OmniLit Acquisition'saverage media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
OmniLit Acquisition Neutral

OmniLit Acquisition has a net margin of 0.00% compared to ThermoGenesis' net margin of -153.43%. OmniLit Acquisition's return on equity of 0.00% beat ThermoGenesis' return on equity.

Company Net Margins Return on Equity Return on Assets
ThermoGenesis-153.43% -4,838.39% -107.53%
OmniLit Acquisition N/A N/A N/A

ThermoGenesis currently has a consensus price target of $5.00, suggesting a potential upside of 833,233.33%. Given ThermoGenesis' higher probable upside, equities research analysts clearly believe ThermoGenesis is more favorable than OmniLit Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ThermoGenesis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
OmniLit Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

ThermoGenesis beats OmniLit Acquisition on 6 of the 9 factors compared between the two stocks.

Get ThermoGenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THMO vs. The Competition

MetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ Exchange
Market Cap$5,000.00$52.78M$5.40B$8.53B
Dividend YieldN/AN/A5.15%4.14%
P/E Ratio0.005.90113.7615.14
Price / Sales0.000.261,483.0493.53
Price / CashN/A25.4339.7134.04
Price / Book0.002.704.665.01
Net Income-$17.98M$385,000.00$119.06M$225.46M
7 Day PerformanceN/A12.65%0.79%0.37%
1 Month PerformanceN/A15.88%5.65%3.57%
1 Year PerformanceN/A101.53%36.80%29.42%

ThermoGenesis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THMO
ThermoGenesis
N/A$0.00
flat
$5.00
+833,233.3%
-99.9%$5,000.00$9.61M0.0025Gap Down
OLITW
OmniLit Acquisition
N/A$0.06
-14.5%
N/AN/A$0.00N/A0.003Gap Up
PCCTW
Perception Capital Corp. II
N/AN/AN/AN/A$0.00N/A0.00N/A
PRENW
Prenetics Global
N/A$0.01
flat
N/A-26.1%$0.00$22.66M0.001Positive News
QSIAW
Quantum-Si
N/A$0.07
flat
N/A-40.7%$0.00$1.70M0.00159Gap Down
SMAPW
SportsMap Tech Acquisition
N/A$0.04
+34.7%
N/A-21.2%$0.00N/A0.00N/AGap Down
KEQU
Kewaunee Scientific
1.4145 of 5 stars
$32.30
-1.1%
N/A+101.5%$91.73M$202.31M5.181,006Analyst Upgrade
News Coverage
MSON
Misonix
N/A$26.54
flat
N/A+0.0%$462.06M$74.02M-31.59254Analyst Forecast
TT
Trane Technologies
4.332 of 5 stars
$392.76
+0.0%
$373.58
-4.9%
+76.1%$88.86B$18.83B38.8540,000Earnings Report
Analyst Downgrade
News Coverage
KEYS
Keysight Technologies
4.4721 of 5 stars
$155.74
-0.2%
$167.67
+7.7%
+25.5%$27.18B$5.00B29.9514,900
FTV
Fortive
4.7481 of 5 stars
$75.15
+0.2%
$89.10
+18.6%
+9.5%$26.45B$6.16B30.1818,000Earnings Report
Analyst Forecast
Analyst Revision
News Coverage

Related Companies and Tools


This page (NASDAQ:THMO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners